- Home
- Cardiology
- Managing Iron Deficiency in Heart Failure: Evidence from the AFFIRM-AHF Trial
4w3 min read
Medical Article
Introduction Iron deficiency is highly prevalent in patients with heart failure (1). It is associated with reduced exercise tolerance, impaired quality of life, and increased risk of hospitalisation and mortality, regardless of the presence of anemia (1). Previous studies have shown that intravenous ferric carboxymaltose improves symptoms and funct

Managing Iron Deficiency in Heart Failure: Evidence from the AFFIRM-AHF Trial
Similar Content

Characteristics, Outcomes and Predictors of Long-Term Mortality for Patients Hospitalized for Acute Heart Failure
150 Reached

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Catheter Ablation for Atrial Fibrillation with HF
691 Reached

Pancytopenia, a rare presentation of hyperthyroidism
832 Reached2 Comments

Patient with History of Atrial Fibrillation
519 Reached3 Likes
